Q2 2023 Talis Biomedical Corp Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Talis Biomedical second-quarter results and business update conference call. (Operator Instructions)
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Ms. Emily Faucette, Senior Vice President Corporate Communications and Investor Relations. Please go ahead.
Good afternoon and thank you. Joining me today are Rob Kelley, our Chief Executive Officer; and Becky Markovich, our Interim Chief Financial Officer.
Earlier today, the company released a business update and financial results for the quarter ended June 3, 2023. A copy of that press release can be accessed on the Investor page of our website at talisbio.com.
Before we get started, I would like to remind you that management will make remarks during this call that are forward-looking statements within the meaning of the Federal Securities laws. These statements involve
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |